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Fetal growth restriction (FGR), previously known as intra-
uterine growth restriction, remains one of the main chal-
lenges in maternity care [1]. Normal fetal growth is
a critical component of a healthy pregnancy and influencessin Chang, Department of
al Cheng Kung University
0403, Taiwan.
du.tw (C.-H. Chang).
C and the Chinese Taipei Society
.07.002the long-term health of the offspring [1]. Fetal growth is
regulated by many factors, including inherited genetic
factors, also known as constitutional factors. Of note, FGR
is defined as a fetus unable to reach its genetically deter-
mined growth potential in the contrary to constitutional
small for gestational age (SGA) [2,3]. Customized standards
for fetal growth and birth weight improve the detection of
FGR by better distinction between physiological and path-
ological smallness and have led to internationally appli-
cable norms. Such developments have resulted in new
insights in the assessment of risk and surveillance during
pregnancy [2].of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
3D Ultrasound in Fetal Growth Restriction 143During the past two decades, three-dimensional ultra-
sound (3DUS) has evolved into a powerful technique [4,5].
In contrast to conventional two-dimensional US (2DUS) that
only allow imaging of single planes, 3DUS offers several
image displays that do not exist in 2DUS imaging. Thus,
3DUS offers a precise demonstration of the normal and
abnormal anatomy of the fetus to the parents even in the
absence of the patient. The digital storage of volumes
permits virtual examinations by reloading of volumes and
navigating through them, and especially benefits evaluation
of fetal growth [5,6].
In the present review, we conducted a systematic review
of the literature in the PubMed database related to the
clinical applications of 3DUS for detecting, evaluating and
predicting FGR. We sought to review 3DUS studies on the
diagnosis, evaluation and prediction of FGR, and to make
recommendations for the possible clinical applications of
3DUS.
Fetal growth restriction
The etiology of FGR is multifactorial, and can be further
divided into maternal and fetal causes, and those resulting
fromuterineeplacental vascular insufficiency; overlapping of
etiological factors is not uncommon. Fetal factors include
aneuploidy, genetic syndromes, and congenital infections.
Common maternal factors include constitutional small,
preeclampsia or hypertension, vasculopathy, cyanotic cardi-
opathies, restrictive pneumopathies, severe renal condi-
tions, autoimmune diseases (e.g., collagenoses and
antiphospholipid antibody syndrome), hereditary or acquired
thrombophilia, hyperhomocysteinemia, and severe anemia
are also associated with FGR.
Improvements have to start from a better definition of
FGR, applying the concept of the fetal growth potential. To
know the fetus is small in utero is the first step. Before the
era of real-time ultrasound, serial fundal height measure-
ment plotted on customized charts was a useful screening
tool, whereas in modern times, fetal biometry and Doppler
flowmetry are the mainstay for investigation and diagnosis
of FGR [2,3,7].
Small for gestational age
Currently, estimated fetal weight or birth weight below
the 10th percentile of certain reference points at a given
gestational week is defined commonly as small for
gestational age (SGA). The thresholds of fifth or third
percentiles are also used [1]. A woman with a prior
gestation complicated by FGR has nearly a 20% risk of
recurrence [1,7,8]. Strategies to predict and prevent the
recurrence are critical in obstetric management. Effec-
tive interventions for prevention of recurrent FGR
include the following: a reproductive plan because
spacing of pregnancies affects their outcome; optimiza-
tion of maternal medical conditions; smoking cessation;
accurate dating by first-trimester ultrasonography and
monitoring of fetal growth with serial sonograms; and
low-dose aspirin (80e160 mg) started before 20 weeks
[9]. In women with nutritional deficiencies, optimizing
caloric intake with low-protein (< 25%) supplementationof 500e1000 calories may prevent recurrent FGR
[2,3,7,8].
Failure to achieve genetic growth potential
The diagnostic elements of FGR are a fetus who is SGA and
below the genetic potential. The growth potential is the
driving force of fetal growth, whereas the placenta as the
sole source of nutrients and oxygen might become the rate-
limiting element of fetal growth if its function is impaired.
Thus, placental dysfunction may prevent the fetus from
reaching its full genetically determined growth potential.
In this sense, fetal growth and its aberration provide an
insight into placental function. Fetal growth is a proxy for
the test of the effectiveness of the placenta, whose func-
tion is otherwise obscured during pregnancy [9].
3DUS: benefits versus conflicts
Traditionally, 3DUS volumes are obtained using the multi-
planar and rotational techniques. The first involves
sectioning the object into several planes separated by
intervals established by the examiner. The outer surface of
the object is traced on each slide, and at the end of the
process, the equipment automatically displays the volume
of the reconstructed object. The rotational technique
[virtual organ computer-aided analysis (VOCAL)] involves
the use of specific software (4D View; GE Healthcare,
Kretztechnik, Zipf, Austria) and rotates the object around
its own axis using a pre-established angle selected by the
operator. The outer contours of consecutive planes dis-
played on the screen are manually traced to obtain area
measurements. At the end of this process, the equipment
automatically calculates the volume and reconstructs the
selected object in a 3D format. All these formulas and
software have been proved to be reliable, valid and
reproducible [10e12].
Besides volumetric measurement, 3DUS assisted Doppler
(3DPD) has also been proved to have potential to under-
stand the association and the pathogenic mechanisms
underlying FGR [13]. Before the era of 3DPD, Doppler
ultrasound by 2D real-time ultrasound had been widely used
for evaluating uteroplacental and fetoplacental perfusion
[14]. For example, umbilical Doppler is a powerful tool in
clinical practice, particularly in the diagnosis and
management of SGA fetuses. Once a fetus has been diag-
nosed as SGA, normal uterine and umbilical flows suggest
that it is small, but otherwise normal, whereas abnormal
uterine/umbilical flows suggest that the growth disorder is
due to an underlying defect in placental development,
which is diagnostic of FGR [15].
Direct investigation of the perfusion of in-vivo placentas
has become possible using 3DPD. Even very small blood
movements within the investigated volume can be detec-
ted by a combination of power and color Doppler ultraso-
nography, and their impact in the given volume,
representing the overall perfusion, is evaluated by indices
computed by built-in algorithms [16]. 3D quantification of
blood flow information in normal fetus from color Doppler
has been obtained in normal fetus among normal fetus in
[17e19].
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Multiple parameters measured by 3DUS have been studied
for estimating fetal body weight, analyzing SGA symmetri-
cally or not, and predicting FGR at later gestational age.
Fetal weight estimations for detecting SGA
The most common definition used equates FGR with a fetus
that is less than the 10th percentile on a weight for
gestational age curve (SGA fetus), although other percen-
tiles (i.e., the fifth or third) have been used. In addition,
there is significant controversy as to which growth curve
should be used [20].
Fetal weight estimation by 3DUS
A number of 3DUS-based fetal weight references have been
published since the late 1990s (Table 1) [21e27]. The volume
of fetal thighs, arms and abdomen, single or in combination,
were most often considered as the variables that correlated
well with fetal weight [21e25]. These cross-sectional
studies can provide a reference only for fetal size, and not
fetal growth velocity. Even in first trimester, embryonic
volume assessment can be accomplished by virtual reality
techniques with 3DUS [27]. The measurement of limb
volume and other soft tissue parameters has been achieved
with the assistance of computer calculations and has been
validated in different ethnic groups [23e25,27e30].
3DUS constructing normal fetal growth reference has
been used to define normal and abnormal fetal growths. For
the prenatal diagnosis of FGR, Chang et al have published
a series of studies by analyzing testing threshold of the
volume of femur, upper arms and humerus (Table 2) [31-
33,38]. Using the 10th percentile as a cut-off value, these
variables, especially the soft tissue of fetal upper arms,
showed good accuracy (93.1% using fetal upper arm, 88.7%
using humerus, and 91.3% using femur) [31e33].
Comparison of 2D and 3D in fetal birth weight
estimation
For the past 30 years, the assessment of fetal size and
growth has been essentially based on predictive models
from 2D ultrasound measurements with the parameters of
BPD (biperiatal diameters), AC (abdominal circumference)
and FL (femur length). Since 3DUS imaging has allowed the
accurate and reliable calculation of fetal organ volumes
[28], some studies have shown that prediction of birth
weight using fetal limb volumetry is more precise than with
formulas using conventional 2DUS [31e33]. Some authors
have debated that the proposed advantage of 3DUS is
simply a result of the small phenotypic difference between
the patients used to create these 3D formulas.
3DUS-assisting volume measurements of fetal
organs
In FGR, reduction is more pronounced for hepatic volume
than for head or upper abdominal circumference; hepaticvolume is a better discriminator than head circumference
but not upper abdominal circumference [28].
Fetal head/intracranial structures
Benavides et al have reported a caseecontrol study that
estimated differences in the volume measured by 3DUS of
intracranial structures (total intracranial, frontal area,
cerebellar and thalamic volumes) between 39 FGR fetuses
and 39 matched appropriate for gestational age (AGA)
fetuses. FGR fetuses showed differences in the volume of
all intracranial structures, except the thalamus, compared
with AGA fetuses, with the largest difference found in the
frontal region [34].
Fetal abdomen
Measurement of the fetal abdominal circumference is the
most sensitive predictor in the fetal weight estimation
formulae using real-time 2DUS parameters [35]. A good
correlation has been found between abdominal circumfer-
ence and length of the right lobe of the liver [36,37].
Fetal limbs
Lee et al have used 3DUS to calculate fractional limb
volumes in the third trimester and have developed
a formula incorporating fractional thigh volume and AC that
gives a slight but statistically significant improvement in
fetal weight estimation compared with traditional 2DUS
techniques [24]. The 3DUS-assisted measurement of volume
of fetal limbs, single or in combination, has been reported
as a good predicting variable of FGR in the series reported
by Chang et al [23,31,32,38]. The reported positive
predictive value of the soft tissue of fetal femur is reported
to be as high as 99%.
Placenta
Wolf et al have reported the second-trimester placental
volume measurement using a modification of the rectan-
gular formula by means of conventional 2DUS [38]. The
introduction of 3DUS could facilitate the novel assessment
of the placenta, such as surface-rendered imaging and
volume measurement [39]. However, studies on the
prediction of adverse pregnancy outcomes, including FGR
and pre-eclampsia, using the placental volume measure-
ment in the first trimester of pregnancy have shown
inconsistent results [39].
3DUS assisting Doppler measurement of blood
flow analysis
The potential value of 3DPD indices is the calculation of
blood perfusion in a volume of tissue, offering a more
complete perspective of regional hemodynamic changes.
3D Doppler ultrasound can observe intraplacental vessel
characteristics such as the density of vessels, branches,
caliber measurements and tortuosity of either the
placental or uterine vessels [40]. 3DPD was found to be
Table 1 Studies of fetal weight estimation by 3DUS.
Studies Year Subjects (n) Used variables Correlation Error Ref.
Brinkley et al 1984 Live fetuses within 48 h prior to
delivery (41)
19 measured variables 0.93 73 g/kg [29]
Lee et al 1997 Term fetuses (18) Abdominal and thigh volumes N.A. 17 fetuses within 10%
of true values
[24]
Chang et al 1997 Fetuses delivered within 48 h after
ultrasound examination (100)
Thigh volume r Z 0.89 Mean percent error (1.5%), [23]
Liang et al 1997 Fetuses delivered within 48 h after
ultrasound examination (105)
Upper arm volume r Z 0.92 Mean percentage
error (0.53%)
[25]
Schild et al 2000 Caucasians with a singleton
pregnancy delivered within
7 d after ultrasound scanning (135)
Upper thigh volume;
arm volume; abdominal volume
0.903e0.973 Mean absolute percentage
error (6  5%)
[21]
Schild et al 2008 Singleton fetuses weighing 1.6 kg
at birth obtained by 2DUS and 3DUS
examination within 1 wk before
delivery (150)
Femur length, biparietal
diameter; abdominal volume
by 3DUS, head circumference,
thigh volume by 3DUS
N.A. Mean percentage
error (0.66  9.55%)
[22]
Lindell et al 2009 Pregnant women in whom the fetus
weight estimation was performed
at 287 d of gestation within 4 d
of delivery (176)
Fetal head, abdomen and femur
using 2DUS, and fetal thigh
volume using 3DUS.
0.67e0.71
(depending on
the formula)
Mean percentage
error (7.0  6.3%)
[27]
2DUS Z two-dimensional ultrasound; 3DUS Z three-dimensional ultrasound; N.A. Z not available.
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146 I-W. Lee et al.superior to 2D power Doppler ultrasound for the detection
of secondary and tertiary stem vessels in the placenta.
Todros has found that the different approaches (morpho-
metric, morphological, mathematical, immunohistochem-
ical and molecular) have contributed to elucidation of
which anomalies of the vascular villous tree underlie
Doppler findings. 3DUS may be useful in the study of feto-
placental perfusion. However, the unsolved question is why
developmental villous tree anomalies occur [41]. Liver,
kidney and brain have been studied showing increasing
blood flow patterns as gestation progresses [17e19].
Three perfusion indices based on the voxel information
of the power Doppler ultrasound signals can be calculated
within the rendered volume: the vascular index (VI,
percentage of voxels in the volume); flow index (FI, mean
voxel intensity in the volume); and vascular/flow index.
Several reports on the fetal brain using 3DPD perfusion
indices have been published, confirming the increment in
brain blood flow perfusion in FGR fetuses [42].
Placental vasculature
3DPD can provide new insights into placental pathophysi-
ology [40]. 3DPD indices [vascularization index (VI), vascu-
larization flow index (VFI) and FI] are reported to be
correlated with placental perfusion. Among them FI
appears to be the most reliable index because of its low
intraplacental variability and identifies the most severe
cases of placental impairment [16]. Yigiter et al to inves-
tigate correlations between first trimester placental
volume and blood flow indexes, bilateral uterine artery
pulsatility indexes, notching, and biochemical parameters:
pregnancy-associated plasma protein-A (PAPP-A), free b-
human chorionic gonadotropin, and insulin-like growth
factor-1 to predict the high-risk pregnancies in the first
trimester. The result showed significant correlations
between placental volume and biochemical parameters,
and [43].
Uterine vessels
In high-risk women, uterine artery Doppler waveform
analysis performs best in the prediction of severe adverse
outcomes, and is better than clinical risk assessment in the
prediction of pre-eclampsia and SGA babies [44,45].
Abnormal uterine artery waveforms are a better predictor
of pre-eclampsia than of FGR. A pulsatility index, alone or
combined with notching, was the most predictive Doppler
index in a meta-analysis [44,46]. Gigano et al have tested
the hemodynamic changes in uterine vessels, measured
with Doppler ultrasound supported by 3D angioimaging, in
the second and third trimester of pregnancy. In this pilot
study, mean uterine artery diameter and blood flow
velocity increased significantly (p < 0.0001) from mid-
gestation to late gestation from 2.6 mm and 67.5 cm/s,
to 3.0 mm and 85.3 cm/s, respectively, yielding an
increasing absolute flow throughout gestation [47]. 3DPD is
a useful and effective method for assessing endometrial
blood flow in IUI cycles and in vitro fertilization cycles, and
good endometrial blood flow is associated with pregnancy
[48,49]. However, there is limited evidence for the
3D Ultrasound in Fetal Growth Restriction 147association between FGR and 3DPD-detected poor endo-
metrial blood flow or high-resistance uterine arteries.
Umbilical vessels
Velamentous insertion of the umbilical cord has been
associated with several obstetric complications including
FGR. The role of 3DUS in evaluating the placental cord
insertion site is no more satisfactory that the combination
of gray-scale ultrasound and color Doppler ultrasound [50].
FGR prediction
Serial prenatal ultrasound for estimating fetal weight has
been proposed to monitor the occurrence of FGR. Indeed,
estimated fetal weight is commonly used as an index of
fetal growth, although in some clinical settings, it is of
limited value to prevent FGR if no adequate parameters to
predict the condition happen in the future. Multidisci-
plinary treatments have been proposed and validated to
improve the outcome by reducing the overall incidence of
complications associated with uteroplacental insufficiency
in high-risk mothers, either with antiphospholipid syndrome
or pre-eclampsia [51,52].
Volume of fetal organs
Due to fetal malnutrition, reduction in fetal hepatic weight
is more pronounced than is reduction in brain weight
because of the brain-sparing effect, which reflects redis-
tribution of fetal blood flow during chronic fetal hypoxemia
[38]. Measurement of fetal hepatic volume may thus
contribute to the early detection of FGR. The decrease in
hepatic volume is more pronounced among fetuses with
body weight lower than average, below the 50th percen-
tile, than is the reduction in head circumference or upper
abdominal circumference [27].
Fetal liver
In fetal growth restriction, reduction is more pronounced
for hepatic volume than for head or upper abdominal
circumference; hepatic volume is a better discriminator
than head circumference but not upper abdominal
circumference [27].
Fetal brain
Prenatal assessment of the fetal head/brain is usually
performed using 2DUS biometric measurements. Benavides-
Serralde et al have studied the intracranial volume
measured by 3DUS in FGR and normal fetuses [34]. Volumes
were satisfactorily obtained in all fetuses. All net volumes
except those for the thalamus were significantly smaller in
FGR fetuses. After adjusting volumes for biparietal diam-
eter, the frontal volume was significantly smaller and the
thalamic volume significantly greater in FGR fetuses than in
fetuses with normal growth. Significant intergroup differ-
ences in the ratios between structures were found only in
those involving the frontal region. The cerebellum diameter
itself is correlated well with gestational age and also the
cerebellar volume measured by 3DUS. FGR fetuses show
differences in the volume of intracranial structurescompared with AGA fetuses, with the largest difference
found in the frontal region. However, interobserver and
intraobserver intraclass correlation coefficients were only
0.66 (95% confidence interval, 0.42e0.79) while measuring
the frontal region.
Volume/vasculature of placenta measured by 3DUS
Although placental growth in the second trimester is too
heterogeneous to justify using this method as a clinical
tool, it can provide new information on placental physi-
ology underlying unfavorable obstetric outcomes [40].
3DPD angiography has been largely used for the subjective
assessment of vascular patterns. With the recent advances
in 3DPD ultrasound as well as quantitative 3DPD histogram
analysis, quantitative and qualitative assessments of the
vascularization and blood flow of the placenta have
become feasible [39]. Rizo et al have reported a study
investigating the first-trimester placental volume and 3DPD
vascularization of pregnancies with low serum PAPP-A
levels, and have related these findings to outcomes of 87
pregnancies. These indices were significantly lower in the
11 pregnancies with birth weights below the 10th percen-
tile and abnormal umbilical Doppler findings later in
gestation. Placental vascular indices were significantly
related to the severity of FGR but not to the levels of
PAPP-A and placental volumes [41]. Recently, Pomorski
et al have conducted a prospective study on a group of 100
normal and 20 FGR pregnancies between 22 and 42 weeks
of gestation. The results showed that quantitative assess-
ment of placental vasculature and volume by means of
3DPD and VOCAL technique is an adjunctive modality for
differentiation between normal and FGR pregnancies [14].
All the fetal cerebral 3D vascular indices, VI, FI and VFI, are
increased in FGR [42]. In these fetuses, there were more
cases suggesting hemodynamic redistribution than ex-
pected by conventional Doppler studies. Morel et al have
conducted an in vivo study confirming a significant corre-
lation between true blood perfusion and quantitative 3D
Doppler indices measured within the uteroplacental unit in
sheep [53].
Conclusion
3DUS has the potential to provide improved visualization of
the fetal anatomic morphology compared with conven-
tional 2DUS. Although no preferred method for 3DUS esti-
mation of fetal weight has emerged from this review, the
advent of 3DUS imaging has allowed the accurate and
reliable calculation of fetal organ and soft tissue volumes.
As reported by recent studies, prediction of birth weight
using fetal limbs or liver is more precise than that obtained
using conventional 2DUS parameters.
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